Form 4: Monte Rosa Therapeutics COO Sells Shares
Insider Transaction (Form 4)
Jennifer Champoux, Chief Operating Officer of Monte Rosa Therapeutics, Inc., sold 4,351 shares of common stock on July 15, 2026 for $23.38 per share.
Summary
- Option exercise/conversion: acquired 4,351 Common Stock at $3.98 ($17,317) on July 15, 2026; holds 66,722 after (Direct).
- Open-market sale: disposed of 4,351 Common Stock at $23.38 ($101,730) on July 15, 2026; holds 62,371 after (Direct).
- Option exercise/conversion: disposed of 4,351 Stock Option (Right to Buy) on July 15, 2026; holds 26,947 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $101,730 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jennifer Champoux — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Option exercise/conversion | Common Stock | 4,351 | $4 | $17.3K | 66,722 |
| 2026-07-15 | Open-market sale | Common Stock | 4,351 | $23 | $101.7K | 62,371 |
| 2026-07-15 | Option exercise/conversion | Stock Option (Right to Buy) | 4,351 | — | — | 26,947 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Option exercise/conversion (4,351 shares) |
| 2026-07-15 | Open-market sale (4,351 shares) |
| 2026-07-15 | Option exercise/conversion (4,351 shares) |
Keywords
insider transaction, Form 4, GLUE, Monte Rosa Therapeutics, Inc., bearish, Jennifer Champoux
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.